Immune Cell Atlas: Neuroinflammation in Neurodegeneration

Executive Summary

This analysis examines immune cell subtypes in the neurodegeneration context, focusing on microglia subtypes (DAM, homeostatic, inflammatory), astrocyte reactivity states (A1/A2), and T-cell infiltration mechanisms. Using existing TREM2 and complement cascade hypotheses as anchors, we synthesize current knowledge and propose new mechanistic hypotheses connecting immune dysregulation to disease progression.

1. Microglia Subtypes

Microglia, the brain’s resident macrophages, exhibit remarkable phenotypic plasticity in neurodegeneration. Three primary states are recognized:

1.1 Homeostatic Microglia

Markers: P2RY12, TMEM119, CX3CR1, IBA1

Function:

• Surveillance of brain parenchyma

• synaptic monitoring and remodeling

• Secretion of neurotrophic factors

Characteristics in Disease:

• Upregulate inflammatory markers

• Downregulate homeostatic markers (lost in AD/PD)

1.2 Disease-Associated Microglia (DAM)

Markers: TREM2-dependent activation, APOE, LPL, CTSD, LGALS3

Activation Pathway (Two-Step Model):

graph TD
    A["Homeostatic Microglia"] --> B["Step 1: TREM2-Independent"]
    B --> C["DAM Level 1"]
    C --> D["Step 2: TREM2-Dependent"]
    D --> E["DAM Level 2"]
    E --> F["SPP1+ Galectin-3+ DAM"]
    
    B -->|"TREM2 R47H"| G["Failed DAM Activation"]
    G --> H["Synaptic Pruning Deficiency"]
    
    D -->|"TREM2 activation"| I["Phagocytic Clearance"]
    D -->|"TREM2 activation"| J["Metabolic Reprogramming"]

DAM Functions:

• Amyloid plaque compaction (early protective)

• Phagocytosis of cellular debris

• Lipid metabolism and cholesterol efflux

• Support of neuronal health

TREM2 Variants (R47H, R62H):

• Reduce microglial clustering around plaques

• Impair metabolic fitness

• Increase AD risk 2-4x

1.3 Inflammatory Microglia (M1-like)

Markers: CD86, iNOS, TNF-alpha, IL-1beta, IL-6, COX-2

Characteristics:

• Strong pro-inflammatory cytokine production

• ROS/RNS generation

• Neurotoxic when chronic

Drivers:

• LPS/IFN-gamma priming

• NLRP3 inflammasome activation

• Aging-associated senescence

2. Astrocyte Reactivity States

Astrocytes adopt context-dependent reactive states, historically divided into A1 (neurotoxic) and A2 (neuroprotective):

2.1 A1 Reactive Astrocytes

Inducers: Microglial IL-1alpha, TNF, C1q

Markers: C3, SERPING1, FKBP5, AMIGO2

Functions:

• Complement-mediated synapse loss

• Phagocytic clearance (increased)

• Secretion of neurotoxic factors

graph TD
    A["Microglial Activation"] --> B["IL-1alpha + TNF + C1q"]
    B --> C["A1 Astrocyte Induction"]
    C --> D["C3 Deposition on Synapses"]
    D --> E["Complement-Mediated Pruning"]
    C --> F["Neurotoxic Factor Secretion"]
    F --> G["Motor Neuron Death"]
    E --> H["Synapse Loss"]

2.2 A2 Reactive Astrocytes

Inducers: Ischemia, ATP, IL-10, CNTF

Markers: S100A10, PTX3, Tm4sf1, Emp1

Functions:

• Neurotrophic factor secretion (GDNF, BDNF)

• Synapse support and repair

• Blood-brain barrier maintenance

2.3 Emerging Complex Nomenclature

Recent single-cell studies reveal astrocyte states are more nuanced:

• Reactome diversity: Region, disease, and age-dependent states

• Dual roles: Same astrocyte can exhibit protective and toxic features

• A1/A2 may represent extremes of a continuum

3. T-Cell Infiltration in Neurodegeneration

Peripheral T-cells penetrate the CNS via:

• Disrupted blood-brain barrier

• Meningeal lymphatic vessels

• Choroid plexus trafficking

3.1 CD4+ T-Cell Roles

Th1 cells:

• Secrete IFN-gamma, IL-2

• Promote pro-inflammatory microglia

Th2 cells:

• Secrete IL-4, IL-5, IL-13

• Anti-inflammatory, may support repair

Th17 cells:

• IL-17 secretion

• Barrier dysfunction

• Implicated in PD pathology

3.2 CD8+ Cytotoxic T-Cells

• Direct neuronal killing (perforin/granzyme)

• Elevated in AD and PD brains

• Correlate with cognitive decline

graph TD
    A["BBB Disruption"] --> B["CD8+ T-Cell Infiltration"]
    A --> C["CD4+ Th1 Infiltration"]
    
    B --> D["Perforin Release"]
    D --> E["Neuronal Apoptosis"]
    
    C --> F["IFN-gamma Secretion"]
    F --> G["Microglial M1 Polarization"]
    G --> H["Chronic Neuroinflammation"]
    
    H --> I["Tau Pathology Spread"]
    H --> J["Synaptic Loss"]

3.3 Regulatory T-Cells (Tregs)

• Normally suppress inflammation

• Function declines with age

• Treg exhaustion accelerates neurodegeneration

4. Inflammatory Pathway Diagram

4.1 Core Neuroinflammatory Cascade

flowchart TD
    subgraph EXTERNAL["External Signals"]
        A["Systemic Inflammation"] --> E["BBB Breakdown"]
        B["Microbial Trigger"] --> E
        C["Aging/Senescence"] --> E
    end
    
    E --> F["Microglial Priming"]
    
    F --> G["NLRP3 Inflammasome"]
    F --> H["NF-kB Activation"]
    
    G --> I["IL-1beta Release"]
    H --> J["TNF-alpha Release"]
    
    I --> K["A1 Astrocyte Induction"]
    J --> K
    
    K --> L["C3 Complement Activation"]
    L --> M["Synaptic Pruning"]
    
    M --> N["Cognitive Decline"]
    
    G --> O["Pyroptosis"]
    O --> P["DAM Dysfunction"]
    
    H --> Q["Endothelial Activation"]
    Q --> R["T-Cell Transmigration"]
    R --> S["CD8+ Cytotoxicity"]
    S --> N

4.2 TREM2-Complement Crosstalk

flowchart TD
    A["TREM2 Activation"] --> B["DAM Formation"]
    A --> C["APOE Binding"]
    
    C --> D["Lipid Metabolism"]
    D --> E["Cholesterol Efflux"]
    
    B --> F["Complement Regulation"]
    F --> G["C1q Suppression"]
    G --> H["Reduced Synaptic Pruning"]
    
    F --> I["C3 Suppression"]
    I --> J["Protected Synapses"]
    
    A --> K["Phagocytic Clearance"]
    K --> L["Amyloid Debris Removal"]
    
    subgraph DYSFUNCTION["TREM2 Dysfunction"]
        M["TREM2 R47H/R62H"] --> N["Failed DAM Activation"]
        N --> O["Uncontrolled Pruning"]
        M --> P["Metabolic Failure"]
        P --> Q["Microglial Senescence"]
    end
    
    O --> R["Excessive Synapse Loss"]
    Q --> S["Chronic Inflammation"]

5. New Hypotheses

Based on this analysis of immune cell subtypes and existing TREM2/complement cascade hypotheses, we propose the following mechanistic hypotheses:

Hypothesis 1: TREM2-APOE4 Axis Drives Metabolic Inflexibility in DAM

Target Genes: TREM2, APOE4, LDHA

Mechanism: APOE4 binding to TREM2 on DAM cells creates a metabolic bottleneck by shunting glucose toward lactate production (via LDHA upregulation) while simultaneously impairing mitochondrial respiration. This creates an ATP-deficit state that prevents sustained phagocytic activity despite initial plaque engagement.

Evidence For:

• APOE4 carriers show reduced microglial clustering around plaques

• TREM2 R47H (APOE binding deficient) shows similar phenotype

• LDHA is upregulated in AD microglia

Testable Prediction: LDHA inhibition or pyruvate supplementation will restore phagocytic function in APOE4+/TREM2-variant microglia.

Confidence: 0.72

Hypothesis 2: C1q-TREM2 Competition for Phosphatidylserine as Pruning Checkpoint

Target Genes: C1QA, C1QB, TREM2, PSR (phosphatidylserine receptor)

Mechanism: Both complement C1q and TREM2 recognize phosphatidylserine (PS) on apoptotic synapse targets. In homeostatic conditions, TREM2 signaling acts as a “don’t-eat-me” checkpoint that pauses complement-mediated pruning. When TREM2 signaling is impaired (R47H variant), C1q dominates, leading to excessive PS-mediated synapse elimination.

Evidence For:

• C1q localizes to synapses before complement C3

• TREM2 deficiency causes increased synaptic pruning in mice

• PS exposure increases on aging neurons

Testable Prediction: Synthetic PS liposomes that engage TREM2 will reduce complement-dependent pruning in TREM2-variant models.

Confidence: 0.68

Hypothesis 3: Astrocyte C3aR Signaling as Bifurcation Point for A1/A2 Fate

Target Genes: C3, C3aR, NFKB1, PPARGC1A

Mechanism: A1 astrocyte induction requires C3aR signaling, which activates NF-kB while simultaneously suppressing PPARGC1A (PGC-1alpha). This creates a feedforward loop: NFKB-driven A1 gene expression + mitochondrial dysfunction. Blocking C3aR in mid-stage neurodegeneration can reset astrocytes to a more homeostatic state by releasing PPARGC1A suppression, restoring metabolic support and reducing neurotoxic factor secretion.

Evidence For:

• C3aR blockade reduces A1 astrocyte markers

• PGC-1alpha restoration improves mitochondrial function

• C3 deposition is elevated in AD/PD brains

Testable Prediction: C3aR antagonists will convert A1 astrocytes toward A2 in human iPSC-derived astrocyte models.

Confidence: 0.75

Hypothesis 4: CD8+ T-Cell Perforin Pathway as Driver of Neuronal Pyramid Loss

Target Genes: GZMB, PRF1, HLA-E, NKG2D

Mechanism: In AD/PD, stressed neurons upregulate NKG2D ligands (MICA/B) that engage NKG2D on infiltrating CD8+ T-cells, triggering perforin/granzyme-mediated cytotoxicity. This mechanism specifically targets large projection neurons with high metabolic demand, explaining the selective vulnerability of cholinergic and dopaminergic populations.

Evidence For:

• CD8+ T-cells are enriched in AD/PD substantia nigra

• NKG2D ligands are induced by cellular stress

• Perforin is required for neuronal loss in PD models

Testable Prediction: NKG2D blockade or perforin inhibition will protect dopaminergic neurons in alpha-synuclein models without compromising general immune surveillance.

Confidence: 0.71

Hypothesis 5: SPP1+ DAM as Source of Autoimmunity in Neurodegeneration

Target Genes: SPP1, GALECTIN3, LGALS3, CXCR4

Mechanism: Late-stage DAM cells (SPP1+, GAL3+) secrete osteopontin (SPP1) which acts as a pro-inflammatory cytokine and autoimmunity driver. SPP1 promotes CXCR4+ T-cell recruitment to the brain and enhances antigen presentation via GAL3-TREM2 interactions. This creates a self-sustaining inflammatory circuit that prevents resolution of neuroinflammation.

Evidence For:

• SPP1+ microglia are enriched in advanced AD

• Osteopontin is elevated in AD CSF

• GAL3-TREM2 interactions modulate inflammatory responses

Testable Prediction: SPP1 neutralizing antibodies or CXCR4 antagonists will reduce T-cell infiltration and break the inflammatory loop in chronic neurodegeneration.

Confidence: 0.66

6. Key Knowledge Gaps

7. References

• Mathys et al. (2017) J. Neurosci. - Disease-associated microglia

• Keren-Shaul et al. (2017) Cell - DAM microglia signature

• Liddelow et al. (2017) Nature - A1 astrocytes

• Deczkowska et al. (2020) Science - TREM2 function

• Yang et al. (2023) Nature Neurosci - T-cell infiltration in AD

• Gratuze et al. (2020) Acta Neuropathologica - TREM2 variants

Analysis generated 2026-04-24 | Task ID: d16-06-3DD3879C